As of Jul 29
| +1.50 / +2.02%|
The 7 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 83.00, with a high estimate of 89.00 and a low estimate of 60.00. The median estimate represents a +9.76% increase from the last price of 75.62.
The current consensus among 10 polled investment analysts is to Hold stock in Abiomed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.